Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;
FEMARA 2.5MG is a non-steroidal aromatase inhibitor medication that is used to treat breast cancer in women who have gone through menopause. The medication works by reducing the amount of estrogen produced in the body, which in turn reduces the growth of the breast cancer.
FEMARA 2.5MG is used to treat breast cancer in postmenopausal women. It is generally used to treat breast cancer that has spread to other parts of the body. It is also used to prevent the cancer from returning after surgery.
HOW TO USE:
FEMARA 2.5MG is generally taken once a day, with or without food. The dosage will depend on the severity of the condition and the instructions given by the doctor. It is important to take the medication at the same time every day, to get the maximum benefit from the medication.
FEMARA 2.5MG should be stored at room temperature, away from direct sunlight and moisture. It should be kept out of the reach of children and pets.
Mechanism of action:
FEMARA 2.5MG works by reducing the amount of estrogen produced in the body, which reduces the growth of breast cancer cells.
Pregnant women should not use FEMARA 2.5MG, as it can cause harm to the developing fetus. Women who are breastfeeding should also avoid using the medication. It may cause dizziness, so it is important to avoid activities that require alertness.
FEMARA 2.5MG should not be used by women who have not gone through menopause, women who are pregnant or breastfeeding, or individuals who are allergic to letrozole.
FEMARA 2.5MG should not be used with certain medications, including estrogen-containing medications, tamoxifen, and raloxifene.
If the prescribed dose is exceeded, it may cause side effects such as dizziness, nausea, and vomiting. It is important to seek medical attention if an overdose is suspected.
The side effects of FEMARA 2.5MG may include hot flashes, nausea, vomiting, weakness, fatigue, headache, joint pain, and increased sweating.